RecruitingNCT06728527
PARTial BREast RECONstruction With Chest Wall Perforator Flap
PartBreCon-Pro Study: PARTial BREast RECONstruction With Chest Wall Perforator Flap, a PROspective Study of Clinical and Patient Reported Outcomes
Sponsor
Cambridge University Hospitals NHS Foundation Trust
Enrollment
1,001 participants
Start Date
Jun 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to ascertain the outcomes following partial breast reconstruction using chest wall perforator flaps after breast conservation surgery.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria4
- Patients undergoing partial breast reconstruction using CWPF for primary breast cancer
- Delayed correction of breast deformity following previous BCS
- Each surgeon is to have performed a minimum of 10 CWPFs
- Each centre anticipates completing a minimum of 10/year
Exclusion Criteria2
- Patients undergoing volume displacement BCS
- Patients undergoing mastectomy +/- immediate breast reconstruction
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06728527
Related Trials
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892139 locations
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
NCT06418204467 locations
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
NCT0618475011 locations
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
NCT059415204 locations
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations